Approval · Notice of Compliance 2011 · 1999
RHOPROIC: Notice of Compliance 2011
Issued May 5, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2011
- Date
- May 5, 1999
- Company
- Rhodiapharm IncLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- DEPAKENE (Abbott Laboratories Co.)
Products in this notice
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 500 MG per CAP